Institution statistics - MEDICINE, HEALTH

UNIVERSITY OF LIVERPOOL - United Kingdom 

Ranking results:

Past rankings:
Subject specific rankings are not yet available..
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 MEDICINE, HEALTH):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 42
As coordinator: 4
As participant: 38
Sole participant: 0
Coordinator / Participant Ratio: 0.11*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2011 0 39.018.585 3.491.605 9
2010 6.246.401 16.999.998 2.616.933 2 2
2009 0 2.703.358 337.920 1
2008 2.224.007 33.057.896 2.920.237 1 7
2006 0 8.434.591 401.647 1
2005 0 10.999.700 379.300 1
2004 0 27.455.111 901.309 4
2003 0 4.499.315 749.886 2
2002 3.045.025 8.415.596 1.436.615 1 7
2001 0 6.055.073 835.984 4
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE75
COMMISSARIAT A L'ENERGIE ATOMIQUE36
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD34
UNIVERSITY COLLEGE LONDON29
KATHOLIEKE UNIVERSITEIT LEUVEN24
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS22
UPPSALA UNIVERSITET22
CONSIGLIO NAZIONALE DELLE RICERCHE21
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM21
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE21
THE UNIVERSITY OF MANCHESTER21
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V20
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV20
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE19
UNIVERSITEIT UTRECHT18
ISTITUTO NAZIONALE DI FISICA NUCLEARE17
KAROLINSKA INSTITUTE17
THE UNIVERSITY OF EDINBURGH17
UNIVERSITY OF NEWCASTLE UPON TYNE17
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS16
UNIVERSITY OF HELSINKI16
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH14
EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH14
KARLSRUHER INSTITUT FUER TECHNOLOGIE14
NATURAL ENVIRONMENT RESEARCH COUNCIL14
STICHTING KATHOLIEKE UNIVERSITEIT14
LUNDS UNIVERSITET13
SCIENCE AND TECHNOLOGY FACILITIES COUNCIL13
UNIVERSITY OF SOUTHAMPTON13
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE12
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN12
NATIONAL UNIVERSITY OF IRELAND GALWAY12
UNIVERSITE LIBRE DE BRUXELLES12
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK12
UNIVERSITY OF GLASGOW12
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS11
POLITECNICO DI MILANO11
UNIVERSIDAD POLITECNICA DE MADRID11
UNIVERSITA DEGLI STUDI DI TORINO11
UNIVERSITY OF BRISTOL11
EUROPEAN MOLECULAR BIOLOGY LABORATORY10
MEDIZINISCHE UNIVERSITAET WIEN10
TECHNISCHE UNIVERSITEIT DELFT10
UNIVERSITA DEGLI STUDI DI PADOVA10
UNIVERSITAET BERN10
UNIVERSITAT DE BARCELONA10
UNIVERSITE CATHOLIQUE DE LOUVAIN10
UNIVERSITEIT LEIDEN10
DANMARKS TEKNISKE UNIVERSITET9
FORSCHUNGSZENTRUM JULICH9
GESELLSCHAFT FUER SCHWERIONENFORSCHUNG MBH9
STIFTELSEN SINTEF9
UNIVERSITAT POLITECNICA DE CATALUNYA9
UNIVERSITY OF BERGEN9
UNIVERSITY OF BIRMINGHAM9
UNIVERSITY OF COPENHAGEN9
DEUTSCHES ZENTRUM FUER LUFT UND RAUMFAHRT EV8
INSTITUTO SUPERIOR TECNICO8
JOZEF STEFAN INSTITUTE8
KING'S COLLEGE LONDON8
KUNGLIGA TEKNISKA HOEGSKOLAN8
RUPRECHT KARLS UNIVERSITAET HEIDELBERG8
STIFTUNG DEUTSCHES ELEKTRONEN SYNCHROTRON DESY8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE8
THE QUEEN'S UNIVERSITY OF BELFAST8
THE UNIVERSITY OF NOTTINGHAM8
THE UNIVERSITY OF SHEFFIELD8
UNIVERSITEIT GENT8
UNIVERSITY OF AARHUS8
UNIVERSITY OF LIMERICK8
UNIVERSITY OF PATRAS8
UNIVERSITY OF WALES CARDIFF8
UNIVERSITY OF YORK8
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM7
ACADEMISCH ZIEKENHUIS LEIDEN7
COMMISSION OF THE EUROPEAN COMMUNITIES DIRECTORATE GENERAL JOINT RESEARCH CENTRE JRC7
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK7
EIDGENOESSISCHE MATERIALPRUEFUNGS UND FORSCHUNGSANSTALT7
INSTITUT PASTEUR7
INSTITUTUL NATIONAL DE CERCETARE DEZVOLTARE PENTRU FIZICA SI INGINERIE NUCLEARA "HORIA HULUBEI"7
OFFICE NATIONAL D'ETUDES ET DE RECHERCHES AEROSPATIALES7
RIJKSUNIVERSITEIT GRONINGEN7
SERVICIO MADRILENO DE SALUD7
STOCKHOLMS UNIVERSITET7
TEL AVIV UNIVERSITY7
UNIVERSITA DEGLI STUDI DI TRENTO7
UNIVERSITAET STUTTGART7
UNIVERSITAIR MEDISCH CENTRUM UTRECHT7
UNIVERSITE DE GENEVE7
UNIVERSITEIT ANTWERPEN7
UNIVERSITY OF LEEDS7
VTT TECHNICAL RESEARCH CENTRE OF FINLAND7
CENTRO DE INVESTIGACIONES ENERGETICAS MEDIOAMBIENTALES Y TECNOLOGICAS6
GOETEBORGS UNIVERSITET6
GRAND ACCELERATEUR NATIONAL D'IONS LOURDS6
ISTITUTO NAZIONALE DI GEOFISICA E VULCANOLOGIA6
JOHNSON MATTHEY PLC6
OESTERREICHISCHE AKADEMIE DER WISSENSCHAFTEN6
OSPEDALE PEDIATRICO BAMBINO GESU6
POLITECHNIKA WARSZAWSKA6
Constancy:

Total number of partners:4808

Partner loyalty:
Frequent Partner: (> 2 projects): 2213
Rare Partner: 2595

Frequent / Rare Partner Ratio: 0.85

Diversity:

Categories:
Category:No:
RTD HORIZONTAL TOPICS166
SOCIAL AND ECONOMIC CONCERNS119
BIOLOGICAL SCIENCES92
INDUSTRY AND TECHNOLOGY89
PROTECTING MAN AND HIS ENVIRON48
AGRICULTURE AND MARINE RESOURC19
ENERGY18
PHYSICAL AND EXACT SCIENCES11
MEASUREMENTS AND STANDARDS4

Project overview:

Start dateProjectacronymrolefundingpartners
2011-04-01REsearch into implementation STrategies to support patients of different ORigins and language background in a variety of European primary care settings RESTOREparticipant2.990.5908
2011-04-01Development of novel diagnostic and therapeutic approaches to improve patient outcome in lung and pancreatic tumours CANCERALIAparticipant2.996.8097
2011-04-01A Nanoscale Artificial Nose to easily detect Volatile Biomarkers at Early stages of Lung Cancer and Related Genetic Mutations LCAOSparticipant4.140.1759
2011-02-01Targeting the tumour microenvironment to improve pancreatic cancer prognosis EPC-TM-Netparticipant3.000.00017
2011-01-01International Data Exchange and Data Representation Standards for Proteomics ProteomeXchangeparticipant1.925.96213
2011-01-01Determining (epi)genetic therapeutic signatures for improving lung cancer prognosis CURELUNGparticipant2.965.74911
2011-01-01Modelling and predicting sensitivity to targeted therapies in colorectal cancers COLTHERESparticipant5.999.30011
2011-01-01Global Research in Paediatrics GRiPparticipant10.000.00023
2011-01-01Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonates TINN2participant5.000.00016
2010-04-01Proposal for the Continuous Proliferation & Simultaneous Maturation of Haematopoietic Stem Cells into Blood Cell Lineages REDONTAPcoordinator2.747.0004
2010-03-01Enhanced Protective Immunity Against Filariasis E PIAFparticipant5.000.00011
2010-02-01Quantifying Weather and Climate Impacts on Health in Developing Countries QWeCIcoordinator3.499.40113
2010-01-01Combined Highly Active Anti-retroviral Microbicides CHAARMparticipant11.999.99834
2009-03-01Mediterranean studies of cardiovascular disease and hyperglycaemia: analytical modelling of population socio-economic transitions MEDCHAMPSparticipant2.703.3588
2008-11-01Evaluation of antibiotics (ciprofloxacin and fluconazole) for the treatment of infections in preterm and term neonates TINNparticipant5.161.00016
2008-11-01INTEGRATION OF THE SYSTEM MODELS OF INSULIN SIGNALLING AND OF MITOCHONDRIAL FUNCTION AND ITS APPLICATION IN THE STUDY OF COMPLEX DISEASES MITINparticipant2.956.4906
2008-05-01Paediatric European network treatment AIDS laboratory network (PENTA LABNET) PENTA-LABNETparticipant1.000.00012
2008-03-01A European Collaboration to optimise research for the care of cancer patients in the last days of life OPCARE9coordinator2.224.0079
2008-03-01The safety pharmacology of artemisinins when used to reverse pathophysiology of malaria in pregnancy ARTEMIPparticipant1.948.8806
2008-02-01European research initiative to develop Imaging Probes for early In-vivo Diagnosis and Evaluation of response to therapeutic substances EURIPIDESparticipant6.994.85014
2008-01-01Fighting osteoporosis by blocking nucleotides: purinergic signalling in bone formation and homeostasis ATPBONEparticipant2.998.6827
2008-01-01Unravelling the molecular basis of common complex human disorders using the dog as a model system LUPAparticipant11.997.99423
2006-08-01Novel molecular diagnostic tools for the prevention and diagnosis of pancreatic cancer MOLDIAG-PACAparticipant8.434.59121
2005-10-01Novel testing strategies for in vitro assessment of allergens SENS-IT-IVparticipant10.999.70029
2004-11-01EMERGING DISEASES IN A CHANGING EUROPEAN ENVIRONMENT EDENparticipant11.497.85650
2004-03-01Transformation of Gas Condensates into Gasoline: Elucidation of the Mechanism and Catalyst Design participant110.0005
2004-01-01Personalized Information Platform for Life and Health Services PIPSparticipant9.847.25516
2004-01-01Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe EUROPEAN LEUKEMIANETparticipant6.000.000177
2003-01-01Obesity and disease in ageing (OB-AGE) OB-AGEparticipant2.486.4936
2003-01-01Keys for quality performance management of the care of older persons in Europe CAREKEYSparticipant2.012.8226
2002-11-01The use of molecular biomarkers in early lung cancer detection (EARLY LUNG CANCER) EARLY LUNG CANCERcoordinator3.045.02515
2002-10-01Computer aided rehabilitation of respiratory disabilities CAREDparticipant1.560.0299
2002-09-01Diagnostics and control of rodent-borne viral zoonoses in europe RODENT-BORNE ZOONOSEparticipant1.499.9735
2002-09-01Orexins / hypocretins - new targets for therapeutic control of feeding and sleeping disorders (OREXINS) OREXINSparticipant997.5455
2002-09-01Pancreatic cancer network: from candidate genes to medical applications (PACA-TARGETS) PACA-TARGETSparticipant676.5586
2002-09-01Paraneoplastic Neurological Syndromes (PNS) clinical and laboratory aspects PNSEURONETWORKparticipant1.243.12119
2002-01-01Surveillance of cerebral palsy in europe 2: support for research and training activities (SCPE2) SCPE2participant249.99614
2002-01-01Enabling autonomy, participation, and well-being in old age: the home environment as a determinant for healthy ageing (ENABLE-AGE) ENABLE-AGEparticipant2.188.3746
2001-11-01Use of electrical stimulation to restore standing in paraplegics with longterm denervated degenerated muscles ddm RISEparticipant1.749.49117
2001-10-01Preclinical studies of novel heparan mimetics for prevention and treatment of tse (HMS AS ANTI PRION DRUGS) HMS AS ANTI PRION DRparticipant1.500.0005
2001-01-01Malarial chemotherapy targeting plasmodial phospholipid biosynthesis: implementation of a prodrug strategy for orally active compounds NOVEL ANTIMALARIALSparticipant1.450.0007
2001-01-01Human cell systems for predicting the allergenicity of genetically engineered proteins. HUCELLALLparticipant1.355.5826

Alias institution names:
  • THE UNIVERSITY OF LIVERPOOL

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum